Thinking beyond routine daily pathology testing in the intensive care unit
The risk of compromising patient care as a result of underinvestigation has to be balanced against wasteful overinvestigation. Getting the balance right is difficult.
Recently I called out a routine blood test, performed on one of our intensive care unit (ICU) patients, that I felt was unnecessary. The resident responded that she had only recently been criticised for not performing exactly the same test in almost identical circumstances by one of my colleagues! This situation isn't new. I remember being faced with the same dilemma when I was a junior doctor. As one of my counterparts observed at the time, "I get criticised for ordering and criticised for not ordering-just choose which way I want to be criticised today."
It is understandable for doctors to try to avoid risking criticism for their decisions, and that they worry more about this than they worry about wasting resources. Such concern easily drives over-investigation and fosters policies where universal testing becomes embedded practice (with a wide range of tests routinely performed, every day, for every patient in the ICU).
In this edition of the Journal Dhanani and colleagues 1 report a study that evaluates a guideline designed to rationalise routine blood testing in ICU. They implemented a number of actions that have previously been advocated. These included staff education together with a new pathology form that highlighted the testing policy. Importantly, consultants undertook test ordering with the need for testing considered during the afternoon ward round the day before the tests were performed. Request forms were completed on this afternoon ward round. The ICU senior registrar was then permitted to add tests that they felt were indicated by an evolving clinical situation.
These measures resulted in a 28% reduction in testing (for the targeted tests) and an estimated annual saving of over A$213,000. No adverse clinical consequences were observed with and without adjusting for severity of illness.
Many of the results of routine testing are unremarkable and add nothing to patient care. One study that looked at results of routine testing observed that nearly 50% of the results were normal and 32% were consecutively normal 2 .
Over the years a number of studies [1] [2] [3] [4] [5] [6] [7] have examined routine blood testing in ICU. All suggest that testing can be reduced, without compromising patient outcomes. In particular, a recent study including 746 patients with gastrointestinal bleeding in ICU found that artificial intelligence could correctly classify necessary and unnecessary laboratory tests in greater than 80% of the occasions for eight common blood tests (calcium, activated partial thromboplastin time, haematocrit, fibrinogen, lactate, platelets, International Normalized Ratio and haemoglobin) 3 , including those who were actively bleeding during the transfusion periods. An average reduction of 50% of the tests was obtained which is substantially better than similar studies based on protocols or guidelines alone (with average performance 37%), as well as the study reported in the current issue of this Journal by Dhanani 1 . The time has come for all ICUs to question how tests are ordered and the extent to which this might be modified without compromising patient care. We should all challenge ourselves in finding innovative ways to achieve more by doing less. Editorial C. F. Corke
